GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $253,000 | -32.9% | 5,822 | -32.7% | 0.03% | -25.6% |
Q1 2022 | $377,000 | -4.1% | 8,656 | -2.9% | 0.04% | -4.9% |
Q4 2021 | $393,000 | +15.2% | 8,916 | 0.0% | 0.04% | +17.1% |
Q3 2021 | $341,000 | -3.9% | 8,916 | 0.0% | 0.04% | 0.0% |
Q2 2021 | $355,000 | +11.6% | 8,916 | 0.0% | 0.04% | +9.4% |
Q1 2021 | $318,000 | -3.0% | 8,916 | 0.0% | 0.03% | -15.8% |
Q4 2020 | $328,000 | -2.4% | 8,916 | 0.0% | 0.04% | -7.3% |
Q3 2020 | $336,000 | -7.7% | 8,916 | 0.0% | 0.04% | -2.4% |
Q2 2020 | $364,000 | +10.6% | 8,916 | +2.7% | 0.04% | -8.7% |
Q1 2020 | $329,000 | -20.9% | 8,684 | -2.0% | 0.05% | +24.3% |
Q4 2019 | $416,000 | +14.0% | 8,861 | +3.5% | 0.04% | +32.1% |
Q3 2019 | $365,000 | +5.8% | 8,561 | -0.6% | 0.03% | +12.0% |
Q2 2019 | $345,000 | -4.2% | 8,611 | 0.0% | 0.02% | +4.2% |
Q1 2019 | $360,000 | +11.1% | 8,611 | +1.6% | 0.02% | 0.0% |
Q4 2018 | $324,000 | -4.7% | 8,476 | 0.0% | 0.02% | -7.7% |
Q3 2018 | $340,000 | +1.5% | 8,476 | +2.0% | 0.03% | -7.1% |
Q2 2018 | $335,000 | +3.1% | 8,306 | 0.0% | 0.03% | 0.0% |
Q1 2018 | $325,000 | +10.2% | 8,306 | 0.0% | 0.03% | +16.7% |
Q4 2017 | $295,000 | -12.5% | 8,306 | 0.0% | 0.02% | -17.2% |
Q3 2017 | $337,000 | -5.9% | 8,306 | 0.0% | 0.03% | -6.5% |
Q2 2017 | $358,000 | +2.3% | 8,306 | 0.0% | 0.03% | +6.9% |
Q1 2017 | $350,000 | +9.4% | 8,306 | 0.0% | 0.03% | +7.4% |
Q4 2016 | $320,000 | -10.6% | 8,306 | 0.0% | 0.03% | -12.9% |
Q3 2016 | $358,000 | -0.6% | 8,306 | 0.0% | 0.03% | -8.8% |
Q2 2016 | $360,000 | +6.8% | 8,306 | 0.0% | 0.03% | +17.2% |
Q1 2016 | $337,000 | -38.8% | 8,306 | -39.2% | 0.03% | -40.8% |
Q4 2015 | $551,000 | +5.0% | 13,656 | 0.0% | 0.05% | 0.0% |
Q3 2015 | $525,000 | -7.7% | 13,656 | 0.0% | 0.05% | +14.0% |
Q2 2015 | $569,000 | -9.7% | 13,656 | 0.0% | 0.04% | -6.5% |
Q1 2015 | $630,000 | +7.9% | 13,656 | 0.0% | 0.05% | -6.1% |
Q4 2014 | $584,000 | -7.0% | 13,656 | 0.0% | 0.05% | -12.5% |
Q3 2014 | $628,000 | -14.0% | 13,656 | 0.0% | 0.06% | -23.3% |
Q2 2014 | $730,000 | 0.0% | 13,656 | 0.0% | 0.07% | -6.4% |
Q1 2014 | $730,000 | +0.1% | 13,656 | 0.0% | 0.08% | -15.2% |
Q4 2013 | $729,000 | +6.4% | 13,656 | 0.0% | 0.09% | +7.0% |
Q3 2013 | $685,000 | +0.4% | 13,656 | 0.0% | 0.09% | -9.5% |
Q2 2013 | $682,000 | – | 13,656 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Black Creek Investment Management Inc. | 7,951,626 | $318,224,000 | 10.49% |
Healthcare Value Capital, LLC | 120,000 | $4,802,000 | 9.01% |
KAHN BROTHERS GROUP INC | 1,605,014 | $64,232,661,000 | 8.03% |
Eversept Partners, LP | 693,685 | $28,091,890 | 7.87% |
EQUITY INVESTMENT CORP | 2,673,764 | $107,004,000 | 3.74% |
Sio Capital Management, LLC | 379,500 | $15,188,000 | 3.66% |
Martin Capital Partners, LLC | 115,448 | $4,620,000 | 3.27% |
Circle Road Advisors LP | 53,028 | $2,122,000 | 3.10% |
Keystone Financial Planning, Inc. | 156,968 | $6,282,000 | 3.07% |
CAMG Solamere Management, LLC | 160,294 | $6,415,000 | 2.94% |